Barry Shaw of the Israel Institute for Strategic Studies and The View from Israel interviewed me last week about the projects that Israel is working on to help combat the coronavirus infection. We hope to produce a monthly video featuring positive Israeli news. Please pass it on. (Please ensure the sound is on.)
Technion Professor Daphne Weihs has developed a fast test to analyze cancer cells. Biopsies are placed into a special gel and measured. Two hours later the extent that the cells have embedded denotes whether they are benign, non-metastatic or metastatic (potential or actual).
An Israeli startup has launched an online platform where people suffering from chronic diseases can share information to learn which treatments work best for their specific condition, based on the experience of their peers. The crowdsourcing site is appropriately called StuffThatWorks. (personal survey for specific conditions)
Professor Peretz Lavie (ex-President of Israel’s Technion Institute) founded the Technion Sleep Medicine Center and authored several books on sleep disorders. Thanks to Technion UK, he is giving a free (donations welcome) webinar on Weds 5th Aug at 6pm UK time – 1pm EST. Register below to view live.
Another exciting webinar from Technion UK featuring Technion Professor Shai Shen-Orr, one of the leading Israeli researchers into the mysteries of the immune system. Also featured is Professor Ester Sager who is developing biosensors to diagnose diseases within minutes.
Israel’s Zebra Medical Vision (reported previously) that uses artificial intelligence technology to help read medical scans, has received US FDA clearance for use of its algorithm to read mammograms. It already received European (CE) approval for its “HealthMammo” solution.
Two recent Jewish immigrants to Israel from France have developed an algorithm named PhysioZoo. Using data from a pulse oximeter (that measures oxygen in blood) the algorithm can determine if a Covid-19 patient is going to develop pneumonia long before symptoms appear.
Scientists at Israel’s Bar-Ilan University have identified low plasma vitamin D level to be an independent risk factor for COVID-19 infection and hospitalization. They studied 782 Israeli COVID-19 positive patients and 7,807 COVID-19 negative patients.
Israel’s BrainStorm (reported previously) reported promising results of pre-clinical trials for its Nurown treatment for Acute Respiratory Distress Syndrome (ARDS) brought about by Covid-19. The NurOwn cells reduced the cytokine storm and lung damage.
Tel Aviv University researchers have developed an innovative cancer treatment. They shoot microbubbles at cancer cells and then blow them up using ultrasound. This destroys 80% of the cancer cells and a simultaneous “trojan horse” immune system gene therapy kills the remaining 20%.